Mutations in PDI and ERp57 were also described in ALS patients, but are thought to be more of a risk factor than directly causative of neurodegeneration (Woehlbier et al., 2016)
Safety Profile & Considerations Current understanding suggests: Generally well-tolerated in research settings No significant toxicity signals in preclinical studies Does not appear to suppress immune function However: Not approved for veterinary use Limited large-scale clinical trials in animals Should only be considered under qualified veterinary supervision What Veterinarians Are Observing In integrative and regenerative veterinary settings, BPC-157 is being explored as part of broader healing protocols
In contrast, Arabidopsis is an organism in which vital redox and organelle regulatory genes can be manipulated without causing lethality, potentially enabling the early cellular-level elucidation of these mechanisms in a living context
Fedorovich, Belarusian State University, Belarus Reviewed by Aksana Hubich, Belarusian State University, Belarus Alexandrina Curpan, Alexandru Ioan Cuza University, Romania Updates Copyright 2025 Zhang, Zou and Cai
